Products

EX3 Stepper

Related Content

The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan. Photo courtesy of Canadian Light Source, University of Saskatchewan

News | Radiation Therapy | May 14, 2020
May 14, 2020 — An innovative radiation treatment t
Medical University of South Carolina researchers have developed and validated prediction tools, known as nomograms, that could be used to help prevent delays in the initiation of radiotherapy after surgery for head and neck cancer

 

Evan Graboyes, M.D., and his team believe their nomogram tools will improve survival rates for head and neck cancer patients. Photo courtesy of MUSC Hollings Cancer Center

 

News | Radiation Oncology | May 14, 2020
May 14, 2020 — More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs i
Maximum-intensity projections, transaxial fusion, and PET images of 18F-PSMA1007 (A-C) and 68Ga-PSMA-11 (D-F) PET/CT scans of 67-y-old patient with GS 8 and PSA 4.9 ng/mL. Marked uptake is seen in urinary bladder and left ureter (arrow) on maximum-intensity projection image of 68Ga-PSMA-11 (D), as opposed to nearly negligible 18F-PSMA-1007 urinary excretion (A). Dominant lesion in left prostatic lobe is evident on both scans (arrowheads). However, second lesion is seen in right lobe only on 18F-PSMA-1007 sc

Maximum-intensity projections, transaxial fusion, and PET images of 18F-PSMA1007 (A-C) and 68Ga-PSMA-11 (D-F) PET/CT scans of 67-y-old patient with GS 8 and PSA 4.9 ng/mL. Marked uptake is seen in urinary bladder and left ureter (arrow) on maximum-intensity projection image of 68Ga-PSMA-11 (D), as opposed to nearly negligible 18F-PSMA-1007 urinary excretion (A). Dominant lesion in left prostatic lobe is evident on both scans (arrowheads). However, second lesion is seen in right lobe only on 18F-PSMA-1007 scan (arrow in C), later verified on pathology as true malignant lesion. Images created by J. Kuten et al., Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

News | Prostate Cancer | May 12, 2020
May 12, 2020 — The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting mali
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...
Figure 1: CT image of lesions in different planes

Figure 1: CT image of lesions in different planes.

Sponsored Content | Case Study | Radiation Oncology | April 30, 2020 | By Christopher Bowen, M.S., DABR
360 Photos | 360 View Photos | April 30, 2020
The company .decimal at ASTRO showed a 3-D prin
Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers

Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers. Image courtesy of Dave Tsai/Los Alamos

News | X-Ray | April 24, 2020
April 24, 2020 — Getting an X-ray at the dentist or